Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - WILLIS TOWERS WATSON PLC

8th Jul 2021 12:54

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

WILLIS TOWERS WATSON PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

ORD

Date of dealing

7 JULY 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD
LongShort
Number(%)Number(%)

(1)

Relevant securities

1,870,958

1.45%

241,524

0.19%

 

(2)

Derivatives (other than options):

72,359

0.06%

227,408

0.18%

 

(3)

Options and agreements to
purchase/sell:

6,100

0.00%

6,100

0.00%

 

(4)

TOTAL:

1,949,417

1.51%

475,032

0.37%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/saleNumber of relevant securitiesPrice per unit
Purchase

1

231.7300 USD
Purchase

1

230.4800 USD
Purchase

1

231.3300 USD
Purchase

2

229.9500 USD
Purchase

2

231.2550 USD
Purchase

2

230.5900 USD
Purchase

5

230.8780 USD
Purchase

6

231.1550 USD
Purchase

8

230.4687 USD
Purchase

30

231.4760 USD
Purchase

100

230.5200 USD
Purchase

100

231.1600 USD
Purchase

100

231.0600 USD
Purchase

100

230.8400 USD
Purchase

200

230.8250 USD
Purchase

368

230.9689 USD
Purchase

495

230.1279 USD
Purchase

812

230.0170 USD
Purchase

1,003

231.0008 USD
Purchase

1,127

231.0654 USD
Purchase

2,533

230.7638 USD
Purchase

4,574

230.6829 USD
Purchase

5,000

229.8125 USD
Purchase

14,590

230.9723 USD
Purchase

18,755

230.7700 USD
Sale

24

230.8800 USD
Sale

36

229.7800 USD
Sale

76

230.5000 USD
Sale

90

231.1222 USD
Sale

104

231.6305 USD
Sale

138

229.7500 USD
Sale

200

230.1300 USD
Sale

211

231.0358 USD
Sale

260

229.7576 USD
Sale

320

229.7639 USD
Sale

400

230.9500 USD
Sale

500

229.7864 USD
Sale

503

230.8635 USD
Sale

624

231.2281 USD
Sale

654

229.7607 USD
Sale

792

230.9915 USD
Sale

851

230.7700 USD
Sale

867

229.7632 USD
Sale

912

230.0722 USD
Sale

952

231.2935 USD
Sale

1,140

231.1509 USD
Sale

2,533

230.7638 USD
Sale

5,832

230.7699 USD
Sale

5,937

230.6762 USD
Sale

12,038

230.9309 USD
Sale

13,899

230.6367 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure

8 JULY 2021

Contact name

Large Holdings Regulatory Operations

Telephone number

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product nameWritten orNumber ofExerciseTypeExpiry
purchasedrelevant securitiespricedate
to which the option
or derivative
relates
Put OptionsPurchased

-100

220.0000

AmericanJul 16, 2021
Call OptionsPurchased

100

240.0000

AmericanJul 16, 2021
Call OptionsPurchased

6,000

220.0000

AmericanJul 16, 2021
Put OptionsPurchased

-6,000

200.0000

AmericanJul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210708005482/en/

Copyright Business Wire 2021


Related Shares:

Barclays
FTSE 100 Latest
Value8,829.31
Change18.27